Sabturani, Nasriya S.
HRN: 21-29-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2022
CEFTRIAXONE 1G (VIAL)
05/01/2022
05/07/2022
IV
1g
Once A Day
Peritonsillar Abscess Right
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes